@article{5136,
  keywords = {brain metastasis, glioblastoma, patient tumor organoid, predictive patient model, temozolomide, tumor heterogeneity},
  author = {Tianping Peng and Xiujian Ma and Wei Hua and Changwen Wang and Youjun Chu and Meng Sun and Valentina Fermi and Stefan Hamelmann and Katharina Lindner and Chunxuan Shao and Julia Zaman and Weili Tian and Yue Zhuo and Yassin Harim and Nadja Stöffler and Linda Hammann and Qungen Xiao and Xiaoliang Jin and Rolf Warta and Catharina Lotsch and Xuran Zhuang and Yuan Feng and Minjie Fu and Xin Zhang and Jinsen Zhang and Hao Xu and Fufang Qiu and Liqian Xie and Yi Zhang and Wei Zhu and Zunguo Du and Lorena Salgueiro and Mark Schneider and Florian Eichhorn and Arthur Lefevre and Stefan Pusch and Valery Grinevich and Miriam Ratliff and Sonja Loges and Lukas Bunse and Felix Sahm and Yangfei Xiang and Andreas Unterberg and Andreas von Deimling and Michael Platten and Christel Herold-Mende and Yonghe Wu and Hai-Kun Liu and Ying Mao},
  title = {Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy},
  year = {2025},
  journal = {Cell Stem Cell},
  volume = {0},
  month = {2025-02-11},
  issn = {1934-5909, 1875-9777},
  url = {https://www.cell.com/cell-stem-cell/abstract/S1934-5909(25)00002-5},
  doi = {10.1016/j.stem.2025.01.002},
  language = {English},
}